HUMULIN R biosynthetic human neutral insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin r biosynthetic human neutral insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; metacresol; hydrochloric acid; glycerol - other conditions: refrigerate - do not freeze. indications: for the treatment of insulin dependent diabetic patients.

HUMULIN NPH biosynthetic human isophane insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin nph biosynthetic human isophane insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: water for injections; sodium hydroxide; protamine sulfate; phenol; dibasic sodium phosphate heptahydrate; glycerol; metacresol; hydrochloric acid; zinc oxide - for the treatment of insulin dependent diabetic patients.

HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

humulin 30/70 biosynthetic human 30% neutral 70% isophane insulin 100iu/ml injection multidose cartridge

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide; protamine sulfate; metacresol; zinc oxide; glycerol; dibasic sodium phosphate heptahydrate; phenol - for the treatment of insulin dependent diabetic patients.

HUMULIN 30/70 biosynthetic human 30% neutral 70% isophane insulin 100IU/mL injection 10mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin 30/70 biosynthetic human 30% neutral 70% isophane insulin 100iu/ml injection 10ml vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: zinc oxide; water for injections; phenol; sodium hydroxide; glycerol; metacresol; protamine sulfate; hydrochloric acid; dibasic sodium phosphate heptahydrate - for the treatment of insulin dependent diabetic patients.

HUMULIN NPH  human insulin 100IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin nph human insulin 100iu/ml injection vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, suspension - excipient ingredients: sodium hydroxide; glycerol; metacresol; zinc oxide; phenol; dibasic sodium phosphate heptahydrate; protamine sulfate; hydrochloric acid; water for injections - this product accepted for registration as 'currently supplied' at the time of commencement of the act. humulin is indicated for the treatment of insulin-dependent diabetic patients.

HUMULIN N PEN SUSPENSION Canada - English - Health Canada

humulin n pen suspension

eli lilly canada inc - insulin biosynthetic human br - suspension - 100unit - insulin biosynthetic human br 100unit - insulins

HUMULIN R (KWIKPEN) SOLUTION Canada - English - Health Canada

humulin r (kwikpen) solution

eli lilly canada inc - insulin biosynthetic human br - solution - 100unit - insulin biosynthetic human br 100unit - insulins

HUMULIN R insulin 100IU/mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

humulin r insulin 100iu/ml injection vial

eli lilly australia pty ltd - insulin, quantity: 100 iu/ml - injection, solution - excipient ingredients: metacresol; glycerol; water for injections; hydrochloric acid; sodium hydroxide - indications as at 05 feb 2002 : humulin is indicated for the treatment of insulin - dependant diabetic patients.

HUMULIN N SUSPENSION Canada - English - Health Canada

humulin n suspension

eli lilly canada inc - insulin nph human dna origin - suspension - 100unit - insulin nph human dna origin 100unit - insulins